|
Name |
Iturin A2
|
Molecular Formula | C48H74N12O14 | |
IUPAC Name* |
3-[(3S,6R,9R,12S,19S,22R,25S)-6,12,22-tris(2-amino-2-oxoethyl)-19-(hydroxymethyl)-9-[(4-hydroxyphenyl)methyl]-2,5,8,11,14,18,21,24-octaoxo-16-undecyl-1,4,7,10,13,17,20,23-octazabicyclo[23.3.0]octacosan-3-yl]propanamide
|
|
SMILES |
CCCCCCCCCCCC1CC(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CO)CC(=O)N)CCC(=O)N)CC(=O)N)CC3=CC=C(C=C3)O)CC(=O)N
|
|
InChI |
InChI=1S/C48H74N12O14/c1-2-3-4-5-6-7-8-9-10-12-28-22-41(67)54-32(23-38(50)64)43(69)56-31(21-27-14-16-29(62)17-15-27)42(68)57-33(24-39(51)65)44(70)55-30(18-19-37(49)63)48(74)60-20-11-13-36(60)47(73)58-34(25-40(52)66)45(71)59-35(26-61)46(72)53-28/h14-17,28,30-36,61-62H,2-13,18-26H2,1H3,(H2,49,63)(H2,50,64)(H2,51,65)(H2,52,66)(H,53,72)(H,54,67)(H,55,70)(H,56,69)(H,57,68)(H,58,73)(H,59,71)/t28?,30-,31+,32-,33+,34+,35-,36-/m0/s1
|
|
InChIKey |
HNAPWDKFUSLFFE-QZBZMMCASA-N
|
|
Synonyms |
Iturin A2
|
|
CAS | NA | |
PubChem CID | 9988651 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 1043.2 | ALogp: | -1.6 |
HBD: | 13 | HBA: | 14 |
Rotatable Bonds: | 22 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 437.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 74 | QED Weighted: | 0.051 |
Caco-2 Permeability: | -5.321 | MDCK Permeability: | 0.00003720 |
Pgp-inhibitor: | 0.058 | Pgp-substrate: | 1 |
Human Intestinal Absorption (HIA): | 0.592 | 20% Bioavailability (F20%): | 1 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.012 | Plasma Protein Binding (PPB): | 53.28% |
Volume Distribution (VD): | 0.392 | Fu: | 37.13% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.002 |
CYP2C19-inhibitor: | 0.009 | CYP2C19-substrate: | 0.017 |
CYP2C9-inhibitor: | 0.117 | CYP2C9-substrate: | 0.032 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.013 |
CYP3A4-inhibitor: | 0.045 | CYP3A4-substrate: | 0.002 |
Clearance (CL): | 1.165 | Half-life (T1/2): | 0.207 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.502 |
Drug-inuced Liver Injury (DILI): | 0.012 | AMES Toxicity: | 0.009 |
Rat Oral Acute Toxicity: | 0.674 | Maximum Recommended Daily Dose: | 0.175 |
Skin Sensitization: | 0.082 | Carcinogencity: | 0.063 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.002 |
Respiratory Toxicity: | 0.003 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002094 | 0.939 | D09PZZ | 0.457 | ||||
ENC003171 | 0.915 | D0M3FJ | 0.444 | ||||
ENC003247 | 0.910 | D0N4OW | 0.444 | ||||
ENC003283 | 0.852 | D0U7SH | 0.442 | ||||
ENC001506 | 0.783 | D0P4VX | 0.427 | ||||
ENC005271 | 0.525 | D0H3MG | 0.414 | ||||
ENC005273 | 0.484 | D08FJL | 0.393 | ||||
ENC001088 | 0.482 | D02SBQ | 0.386 | ||||
ENC005275 | 0.472 | D0J7XL | 0.379 | ||||
ENC005274 | 0.461 | D00GNJ | 0.374 |